## BACKGROUND. Chemotherapy-induced emesis is one of the most disturbing side effects of cancer therapy. Control of acute emesis has improved substantially during recent years, but control of delayed emesis and nausea remains a challenging problem. The role of 5-HT3 receptor antagonists in the tre
β¦ LIBER β¦
Comparison of three tropisetron-containing antiemetic regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nausea
β Scribed by S. Drechsler; U. Bruntsch; J. Eggert; J. Grote-Kiehn; H. Gosse; M. Bangerter; D. Ukena; C. Oehm; J. Mezger; L. Faerber; W. Imhoff; M. Untch; W. M. Gallmeier
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 175 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A study evaluating the efficacy and tole
β
Bengt G. Sorbe; Anne-Marie Berglind; HΓ₯kan Andersson; Karin Boman; Thomas HΓΆgber
π
Article
π
1998
π
John Wiley and Sons
π
English
β 189 KB
π 2 views
Comparison of granisetron, ondansetron,
β
Ivo W. Tremont-Lukats; Gilda M. Teixeira
π
Article
π
1996
π
John Wiley and Sons
π
English
β 204 KB
π 2 views
Comparison of granisetron, ondansetron,
β
Giovanni Mantovani; Antonio MacciΓ²; Alessandro Bianchi; Luigi Curreli; Massimo G
π
Article
π
1996
π
John Wiley and Sons
π
English
β 609 KB
ari, for h's helpful advice in the statistical evaluation of the results.
A double-blind, crossover, randomized do
β
Su G. Berrak; Nihal Ozdemir; Nadi Bakirci; Emine Turkkan; Cengiz Canpolat; Bahar
π
Article
π
2007
π
Springer-Verlag
π
English
β 122 KB
Effectiveness of a single-day three-drug
β
Steven M. Grunberg; Matthew Dugan; Hyman Muss; Marie Wood; Susan Burdette-Radoux
π
Article
π
2008
π
Springer-Verlag
π
English
β 148 KB
A double-blind comparison of the efficac
β
David S. Ettinger; Peter D. Eisenberg; David Fitts; Carl Friedman; Karen Wilson-
π
Article
π
1996
π
John Wiley and Sons
π
English
β 848 KB
The purpose of this study was to define an optimal administration schedule of granisetron for patients receiving moderately ernetogenic chemotherapy by comparing the antiemetic efficacy and safety of 2 mg of the drug administered orally. ## METHODS. In this double-blind, randomized, parallel stud